These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 11365250
21. Achieving an HIV vaccine: the need for an accelerated national campaign. Marlink R. J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):35-7. PubMed ID: 11364812 [Abstract] [Full Text] [Related]
22. [Vaccines against HIV]. Holm-Hansen C. Tidsskr Nor Laegeforen; 2006 Nov 30; 126(23):3117-20. PubMed ID: 17160118 [Abstract] [Full Text] [Related]
23. National vaccine effort seen as insufficient. AIDS Alert; 1998 Jan 30; 13(1):4-6. PubMed ID: 11364864 [Abstract] [Full Text] [Related]
24. [AIDS vaccines: promises and reality]. Goudsmit J. Ned Tijdschr Geneeskd; 2001 Jun 30; 145(26):1241-5. PubMed ID: 11455689 [Abstract] [Full Text] [Related]
25. AIDS vaccines. IAVI issues blueprint to assure global access. AIDS Wkly; 2000 Jul 31; ():23-5. PubMed ID: 12322551 [Abstract] [Full Text] [Related]
26. An HIV vaccine: how and when? Esparza J. Bull World Health Organ; 2001 Jul 31; 79(12):1133-7. PubMed ID: 11799445 [Abstract] [Full Text] [Related]
27. HIV vaccine development. Johnston MI. Dev Biol (Basel); 2002 Jul 31; 110():57-63. PubMed ID: 12477307 [Abstract] [Full Text] [Related]
28. Designing HIV vaccines for developing countries. Abrams S. Harv AIDS Rev; 1995 Jul 31; ():17-9. PubMed ID: 12319991 [Abstract] [Full Text] [Related]
29. Progress and obstacles in the development of an AIDS vaccine. Letvin NL. Nat Rev Immunol; 2006 Dec 31; 6(12):930-9. PubMed ID: 17124514 [Abstract] [Full Text] [Related]
30. Clinton sets goal of having an AIDS vaccine in 10 years. AIDS Policy Law; 1997 Jun 13; 12(11):3. PubMed ID: 11364387 [Abstract] [Full Text] [Related]
31. IAVI advances AIDS vaccine research... International AIDS Vaccine Initiative. Dove A. Nat Med; 1999 Jan 13; 5(1):5. PubMed ID: 9883820 [No Abstract] [Full Text] [Related]
32. State of the science. HIV vaccine development. Grady C, Kelly G. Nurs Clin North Am; 1996 Mar 13; 31(1):25-39. PubMed ID: 8604385 [Abstract] [Full Text] [Related]
33. Activism needed for vaccines to reach South. Bridg Wash D C; 1998 Jun 30; (2):4-5. PubMed ID: 12222193 [Abstract] [Full Text] [Related]
34. [The quest for an HIV vaccine]. Girard MP. Bull Acad Natl Med; 2005 May 30; 189(5):831-44; discussion 844. PubMed ID: 16433455 [Abstract] [Full Text] [Related]
35. [HIV/AIDS vaccines: heading for new vaccine approaches?]. Girard MP. Bull Soc Pathol Exot; 2008 Jun 30; 101(3):220-6. PubMed ID: 18681215 [Abstract] [Full Text] [Related]
37. Progress towards an HIV-1 subtype C vaccine. Nkolola JP, Essex M. Vaccine; 2006 Jan 23; 24(4):391-401. PubMed ID: 16139396 [Abstract] [Full Text] [Related]
38. HIV vaccines advocacy: the role of UNAIDS. Research and accessibility. Piot P. TB HIV; 1996 Jan 23; (11):7-9. PubMed ID: 12179807 [Abstract] [Full Text] [Related]
39. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives. Hecht R, Suraratdecha C. PLoS Med; 2006 Sep 23; 3(10):e398. PubMed ID: 16953657 [Abstract] [Full Text] [Related]
40. Market incentives, human lives, and AIDS vaccines. Craddock S. Soc Sci Med; 2007 Mar 23; 64(5):1042-56. PubMed ID: 17113203 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]